Laboratory Corp Q2 2024 Adj. EPS $3.94 Beats $3.78 Estimate, Sales $3.220B Beat $3.185B Estimate
Portfolio Pulse from Benzinga Newsdesk
Laboratory Corp (NYSE:LH) reported Q2 2024 adjusted EPS of $3.94, beating the $3.78 estimate and showing a 15.2% increase from last year. Sales were $3.220 billion, surpassing the $3.185 billion estimate and marking a 6.13% increase from the previous year.
August 01, 2024 | 10:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Laboratory Corp (NYSE:LH) reported strong Q2 2024 earnings, with adjusted EPS of $3.94 beating estimates by 4.23% and sales of $3.220 billion exceeding expectations by 1.09%. Both EPS and sales showed significant year-over-year growth.
The strong earnings report, with both EPS and sales beating analyst estimates and showing significant year-over-year growth, is likely to positively impact Laboratory Corp's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100